Breakfast symposium1 Sponsored by Lilly Thursday, 7 November 07:30~08:30 / Convention hall A
Chair: Soon Jib Yoo
 
Guntram Schernthaner
Rudolfstiftung Hospital, Austria

BS-01

The role of mixtures in the initiation and intensification of insulin treatment for patients with type 2 diabetes
Breakfast symposium2 Sponsored by Novartis Thursday, 7 November 07:30~08:30 / Convention hall B
Chair: You Hern Ahn
 
Mi-Kyung Kim

BS-02

Considerations for managing special populations with diabetes – role of vildagliptin
Breakfast symposium3 Sponsored by Daewoong Friday, 8 November 07:30~08:30 / Convention hall A
Chair: Hyun Chul Lee
 
Sihoon Lee
Gachon University, Korea

BS-03

Sitagliptin: optimal choice of DPP-4 inhibitor for patients with T2DM
Breakfast symposium4 Sponsored by Boehringer Ingelheim Friday, 8 November 07:30~08:30 / Convention hall B
Chair: Hyoung Woo Lee
 
Sung Hee Choi

BS-04

Differentiating linagliptin from other DPP-4 inhibitors
Breakfast symposium5 Sponsored by Sanofi Aventis Friday, 8 November 07:30~08:30 / Convention hall C
Chair: Dong-Sun Kim
 
Eun Gyoung Hong
Hallym University, Korea

BS-05

What can we do better for the compliance of type 2 diabetic patients
Breakfast symposium6 Sponsored by MSD Saturday, 9 November 07:30~08:30 / Convention hall A
Chair: Ho Sang Shon
 
Hye Jin Yoo
Korea University, Korea

BS-06

Efficacy and safety of Sitagliptin in T2DM with CKD and beyond glucose control
Breakfast symposium7 Sponsored by JW Pharmaceutical Saturday, 9 November 07:30~08:30 / Convention hall B
Chair: Duk Kyu Kim
 
Masato Odawara
Tokyo Medical University, Japan

BS-07

Pitavastatin and incident T2DM
Luncheon symposium1 Sponsored by Astrazeneca Thursday, 7 November 12:10~13:10 / Convention hall A,B,C
Chair: Kyu Jeung Ahn
 
Richard E. Gilbert
University of Toronto, Canada

LS-01

Clinical implications of SAVOR TIMI-53 in type 2 diabetes mellitus

Luncheon symposium2 Sponsored by CJ Thursday, 7 November 12:10~13:10 / Emerald hall A, B
Chair: Joong Yeol Park
 
In-Kyung Jeong
Kyung Hee University, Korea

LS-02

Initial therapy with VOGMET® in patients with type 2 diabetes

Luncheon symposium3 Sponsored by ChongKunDang Thursday, 7 November 12:10~13:10 / Grand ballroom A,B,C
Chair: Sung-Woo Park
 
Sin Gon Kim
Korea University, Korea

LS-03

Lobeglitazone, a novel PPAR-γ agonist with balanced efficacy and safety

Luncheon symposium4 Sponsored by Sanofi Aventis Friday, 8 November 12:30~13:30 / Convention hall A
Chair: Yong Seong Kim
 
Eun Seok Kang
Yonsei University, Korea

LS-04

Rediscovering the one insulin you know: latest update focused on CV risk & new clinical trial

Luncheon symposium5 Sponsored by Takeda Friday, 8 November 12:30~13:30 / Convention hall B
Chair: Young Seol Kim
 
Yukio Tanizawa
Yamaguchi University, Japan

LS-05

Refining type 2 diabetes therapy: focusing on ENDURE and EXAMINE trials

Luncheon symposium6 Sponsored by Handok Friday, 8 November 12:30~13:30 / Convention hall C
Chair: Seong Yeon Kim
 
Chang Beom Lee
Hanyang University, Korea

LS-06

Intervening early in type 2 diabetes with vildagliptin
Luncheon symposium7 Sponsored by Novonordisk Friday, 8 November 12:30~13:30 / Emerald hall A, B
Chair: Hyung Joon Yoo
 
Chong Hwa Kim
Sejong General Hospital, Korea

LS-07

The role of modern insulin in T2DM management (focus on high ratio premixed insulin)
Luncheon symposium8 Sponsored by MSD Friday, 8 November 12:30~13:30 / Grand ballroom A,B,C
Chair: Yong Ki Kim
 
Soo Lim
Seoul National University, Korea

LS-08

Comparison between sitagliptin as add-on therapy to insulin and insulin dose-increase therapy in uncontrolled Korean type 2 diabetes: CSI study
Luncheon symposium9 Sponsored by BMS Saturday, 9 November 12:00~13:00 / Convention hall A,B,C
Chair: Min Young Chung
 
Kyu Yeon Hur
Sungkyunkwan University, Korea

LS-09

Novel strategy for achieving glucose control in T2DM: Inhibition of renal glucose reabsorption
Luncheon symposium10 Sponsored by Astrazeneca Saturday, 9 November 12:00~13:00 / Emerald hall A, B
Chair: Sung Koo Kang
 
Eun-Jung Rhee
Sungkyunkwan University, Korea

LS-10

The atherogenic dyslipidemia of diabetes mellitus: not just a question of LDL-C
Luncheon symposium11 Sponsored by Jeil Saturday, 9 November 12:00~13:00 / Grand ballroom A,B,C
Chair: Kyung Ho Lim
 
Sung Rae Kim
The Catholic University of Korea, Korea

LS-11

Eye on Korean data: lipid management in Korean DM patients , AMADEUS study
Quick Menu
Registration
Abstract
On-line submission
Venue
venue
Top